A. Gentles, A. Newman, C. Liu, S. Bratman, W. Feng et al., The prognostic landscape of genes and infiltrating immune cells across human cancers, Nature Medicine, vol.30, issue.8, pp.938-983, 2015.
DOI : 10.18637/jss.v030.i10

D. Kabelitz and D. Wesch, Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors, Crit Rev Immunol, vol.23, pp.5-6, 2003.

T. Lança, M. Costa, N. Gonçalves-sousa, M. Rei, A. Grosso et al., Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic ???? T Lymphocytes to Tumor Beds, The Journal of Immunology, vol.190, issue.12, pp.6673-80, 2013.
DOI : 10.4049/jimmunol.1300434

M. Thomas, R. Badwe, R. Deshpande, U. Samant, and S. Chiplunkar, Role of adhesion molecules in recruitment of V??1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patients, Cancer Immunology, Immunotherapy, vol.50, issue.4, pp.218-2510, 1007.
DOI : 10.1007/s002620100190

M. Zocchi, M. Ferrarini, and C. Rugarli, Selective lysis of the autologous tumor by ??TCS1+ ??/??+ tumor-infiltrating lymphocytes from human lung carcinomas, European Journal of Immunology, vol.87, issue.12, pp.2685-2694, 1990.
DOI : 10.1002/eji.1830201224

S. Mattarollo, T. Kenna, M. Nieda, and A. Nicol, Chemotherapy and zoledronate sensitize solid tumour cells to V??9V??2 T cell cytotoxicity, Cancer Immunology, Immunotherapy, vol.47, issue.18, pp.1285-97, 2007.
DOI : 10.4049/jimmunol.174.3.1338

J. Fisher, J. Heuijerjans, M. Yan, K. Gustafsson, and J. Anderson, ???? T cells for cancer immunotherapy, OncoImmunology, vol.154, issue.1, 2014.
DOI : 10.1158/0008-5472.CAN-10-3862

A. Cordova, F. Toia, L. Mendola, C. Orlando, V. Meraviglia et al., Characterization of Human ???? T Lymphocytes Infiltrating Primary Malignant Melanomas, PLoS ONE, vol.56, issue.11, 2012.
DOI : 10.1371/journal.pone.0049878.t001

G. Siegers, L. Lamb, and . Jr, Cytotoxic and Regulatory Properties of Circulating V??1+ ???? T Cells: A New Player on the Cell Therapy Field?, Molecular Therapy, vol.22, issue.8, pp.1416-1438, 2014.
DOI : 10.1038/mt.2014.104

G. Peng, H. Wang, W. Peng, Y. Kiniwa, K. Seo et al., Tumor-Infiltrating ???? T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway, Immunity, vol.27, issue.2, pp.334-382, 2007.
DOI : 10.1016/j.immuni.2007.05.020

URL : http://doi.org/10.1016/j.immuni.2007.05.020

D. Asaro, M. , L. Mendola, C. , D. Liberto et al., V??9V??2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells, The Journal of Immunology, vol.184, issue.6, pp.3260-3268, 2010.
DOI : 10.4049/jimmunol.0903454

T. Lança, D. Correia, C. Moita, H. Raquel, A. Neves-costa et al., The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to gammadelta T-cell cytotoxicity, Blood, vol.11512, pp.2407-2418, 2010.

L. Couzi, Y. Levaillant, A. Jamai, V. Pitard, R. Lassalle et al., Cytomegalovirus-Induced ???? T Cells Associate with Reduced Cancer Risk after Kidney Transplantation, Journal of the American Society of Nephrology, vol.21, issue.1, pp.181-189, 2010.
DOI : 10.1681/ASN.2008101072

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799280

L. Lamb, P. Henslee-downey, R. Parrish, K. Godder, J. Thompson et al., Rapid Communication: Increased Frequency of TCR????+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for Leukemia, Journal of Hematotherapy, vol.5, issue.5, pp.503-512, 1996.
DOI : 10.1089/scd.1.1996.5.503

C. Ma, Q. Zhang, J. Ye, F. Wang, Y. Zhang et al., Tumor-Infiltrating ???? T Lymphocytes Predict Clinical Outcome in Human Breast Cancer, The Journal of Immunology, vol.189, issue.10, pp.5029-5065, 2012.
DOI : 10.4049/jimmunol.1201892

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832413

E. Champagne, ???? T cell Receptor Ligands and Modes of Antigen Recognition, Archivum Immunologiae et Therapiae Experimentalis, vol.56, issue.Pt 2, pp.117-154, 2011.
DOI : 10.1099/jmm.0.46882-0

C. Tyler, D. Doherty, B. Moser, and M. Eberl, Human V??9/V??2 T cells: Innate adaptors of the immune system, Cellular Immunology, vol.296, issue.1, pp.10-21, 2015.
DOI : 10.1016/j.cellimm.2015.01.008

F. Halary, V. Pitard, D. Dlubek, R. Krzysiek, H. De-la-salle et al., ???? T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells, The Journal of Experimental Medicine, vol.96, issue.10, pp.1567-78, 2005.
DOI : 10.1016/S1074-7613(02)00447-8

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212929

C. Willcox, V. Pitard, S. Netzer, L. Couzi, M. Salim et al., Cytomegalovirus and tumor stress surveillance by binding of a human ???? T cell antigen receptor to endothelial protein C receptor, Nature Immunology, vol.16, issue.9, pp.872-881, 2012.
DOI : 10.1016/S1074-7613(00)80035-7

S. Ehl, K. Schwarz, A. Enders, U. Duffner, U. Pannicke et al., A variant of SCID with specific immune responses and predominance of ???? T cells, Journal of Clinical Investigation, vol.115, issue.11, pp.3140-3148, 2005.
DOI : 10.1172/JCI25221

D. Paoli, P. Gennari, D. Martelli, P. Basaglia, G. Crovatto et al., A subset of ???? lymphocytes is increased during HIV-1 infection, Clinical & Experimental Immunology, vol.82, issue.2, pp.187-91, 1991.
DOI : 10.1093/infdis/161.5.1013

D. Fenoglio, A. Poggi, S. Catellani, F. Battaglia, A. Ferrera et al., V??1 T lymphocytes producing IFN-?? and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans, Blood, vol.113, issue.26, pp.6611-6619, 2009.
DOI : 10.1182/blood-2009-01-198028

H. Fausther-bovendo, N. Wauquier, J. Cherfils-vicini, I. Cremer, P. Debré et al., NKG2C is a major triggering receptor involved in the V??1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells, AIDS, vol.22, issue.2, pp.217-243, 2008.
DOI : 10.1097/QAD.0b013e3282f46e7c

K. Hudspeth, M. Fogli, D. Correia, J. Mikulak, A. Roberto et al., Engagement of NKp30 on V??1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication, Blood, vol.119, issue.17, pp.4013-4019, 2012.
DOI : 10.1182/blood-2011-11-390153

B. Poonia and C. Pauza, Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity, Cytotherapy, vol.14, issue.2, pp.173-81, 2011.
DOI : 10.3109/14653249.2011.623693

H. Li and C. Pauza, HIV envelope-mediated, CCR5/??4??7-dependent killing of CD4-negative ???? T cells which are lost during progression to AIDS, Blood, vol.118, issue.22, pp.5824-5855, 2011.
DOI : 10.1182/blood-2011-05-356535

C. Spencer, G. Abate, I. Sakala, M. Xia, S. Truscott et al., Granzyme A produced by ?(9)?(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen, PLoS Pathog, vol.9, issue.1, 2013.

C. Agrati, D. Offizi, G. Narciso, P. Abrignani, S. Ippolito et al., Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons, Mol Med, vol.7, issue.1, pp.11-20, 2001.

C. Agrati, D. Offizi, G. Narciso, P. Selva, C. Pucillo et al., 1 Compartmentalization and Hepatitis C Virus Disease Progression Independent of Highly Active Antiretroviral Therapy, AIDS Research and Human Retroviruses, vol.17, issue.14, pp.1357-631008892220152596614, 1089.
DOI : 10.1089/08892220152596614

S. Barcy, D. Rosa, S. Vieira, J. Diem, K. Ikoma et al., ????+ T Cells Involvement in Viral Immune Control of Chronic Human Herpesvirus 8 Infection, The Journal of Immunology, vol.180, issue.5, pp.3417-3442, 2008.
DOI : 10.4049/jimmunol.180.5.3417

J. Déchanet, P. Merville, A. Lim, C. Retière, V. Pitard et al., Implication of ???? T cells in the human immune response to cytomegalovirus, Journal of Clinical Investigation, vol.103, issue.10, pp.1437-1486, 1999.
DOI : 10.1172/JCI5409

D. Vermijlen, M. Brouwer, C. Donner, C. Liesnard, M. Tackoen et al., Human cytomegalovirus elicits fetal ???? T cell responses in utero, The Journal of Experimental Medicine, vol.72, issue.4, pp.807-828, 2010.
DOI : 10.4049/jimmunol.168.4.1566

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856038

A. Knight, A. Madrigal, S. Grace, J. Sivakumaran, P. Kottaridis et al., The role of V??2-negative ???? T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation, Blood, vol.116, issue.12, pp.2164-72, 2010.
DOI : 10.1182/blood-2010-01-255166

B. Autran, F. Triebel, C. Katlama, W. Rozenbaum, T. Hercend et al., T cell receptor gamma/delta+ lymphocyte subsets during HIV infection, Clin Exp Immunol, vol.75, issue.2, pp.206-216, 1989.

A. Glatzel, D. Wesch, F. Schiemann, E. Brandt, O. Janssen et al., Patterns of Chemokine Receptor Expression on Peripheral Blood ???? T Lymphocytes: Strong Expression of CCR5 Is a Selective Feature of V??2/V??9 ???? T Cells, The Journal of Immunology, vol.168, issue.10, pp.4920-4929, 2002.
DOI : 10.4049/jimmunol.168.10.4920

Z. Chen and N. Letvin, V??2V??2+ T cells and anti-microbial immune responses, Microbes and Infection, vol.5, issue.6, pp.491-499, 2003.
DOI : 10.1016/S1286-4579(03)00074-1

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873077/pdf

R. Boismenu, L. Feng, Y. Xia, J. Chang, and W. Havran, Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia, J Immunol, vol.157, issue.3, pp.985-92, 1996.

G. Qin, Y. Liu, J. Zheng, I. Ng, Z. Xiang et al., Type 1 Responses of Human V??9V??2 T Cells to Influenza A Viruses, Journal of Virology, vol.85, issue.19, pp.10109-10125, 2011.
DOI : 10.1128/JVI.05341-11

F. Poccia, L. Battistini, B. Cipriani, G. Mancino, F. Martini et al., Phosphoantigen???Reactive V??9V??2 T Lymphocytes Suppress In Vitro Human Immunodeficiency Virus Type 1 Replication by Cell???Released Antiviral Factors Including CC Chemokines, The Journal of Infectious Diseases, vol.180, issue.3, pp.858-6110314925, 1086.
DOI : 10.1086/314925

J. Bruder, K. Siewert, B. Obermeier, J. Malotka, P. Scheinert et al., Target Specificity of an Autoreactive Pathogenic Human ????-T Cell Receptor in Myositis, Journal of Biological Chemistry, vol.42, issue.25, pp.20986-95, 2012.
DOI : 10.1038/nrrheum.2010.2

U. Laggner, D. Meglio, P. Perera, G. Hundhausen, C. Lacy et al., Identification of a Novel Proinflammatory Human Skin-Homing V??9V??2 T Cell Subset with a Potential Role in Psoriasis, The Journal of Immunology, vol.187, issue.5, pp.2783-93, 2011.
DOI : 10.4049/jimmunol.1100804

C. Hu, L. Qian, Y. Miao, Q. Huang, P. Miao et al., Antigen-presenting effects of effector memory V??9V??2 T cells in rheumatoid arthritis, Cellular and Molecular Immunology, vol.20, issue.3, pp.245-54, 2012.
DOI : 10.1182/blood-2003-04-1016

X. Li, N. Kang, X. Zhang, X. Dong, W. Wei et al., Generation of Human Regulatory ???? T Cells by TCR???? Stimulation in the Presence of TGF-?? and Their Involvement in the Pathogenesis of Systemic Lupus Erythematosus, The Journal of Immunology, vol.186, issue.12, pp.6693-700, 2011.
DOI : 10.4049/jimmunol.1002776

A. Toulon, L. Breton, K. Taylor, M. Tenenhaus, D. Bhavsar et al., A role for human skin???resident T cells in wound healing, The Journal of Experimental Medicine, vol.102, issue.4, pp.743-50, 2009.
DOI : 10.1046/j.1523-1747.1998.00265.x

N. Fay, E. Larson, and J. Jameson, Chronic Inflammation and ???? T Cells, Frontiers in Immunology, vol.107, issue.8, 2016.
DOI : 10.1016/j.rmed.2012.11.012